Yet Another Bulletin Board

Welcome, Guest. Please Login or Register.
Nov 25th, 2024, 12:57pm

Home Home Help Help Search Search Members Members Member Map Member Map Login Login Register Register
Clusterheadaches.com Message Board « Bad day for Glaxo »


   Clusterheadaches.com Message Board
   New Message Board Archives
   Medications, Treatments, Therapies 2004
(Moderator: DJ)
   Bad day for Glaxo
« Previous topic | Next topic »
Pages: 1  Reply Reply Notify of replies Notify of replies Send Topic Send Topic Print Print
   Author  Topic: Bad day for Glaxo  (Read 355 times)
tommyD
New Board Hall of Famer
USA 
*****



Anything not impossible is compulsory.

   
WWW

Gender: male
Posts: 525
Bad day for Glaxo
« on: Feb 14th, 2004, 7:13am »
Quote Quote Modify Modify

They got supoenaed by the feds over for their marketing and promotion practices of some major drugs, including Imitrex.
Also, their stock dropped Friday. but that was mainly because their profits are down.  
Here’s some links and excrepts. If the links don’t work, go to Google News and search for GlaxoSmithKline.
 
http://www.ajc.com/business/content/business/ap/ap_story.html/Financial/ AP.V8297.AP-GlaxoSmithKline.html
 
GlaxoSmithKline Gets Federal Subpoena
 
WASHINGTON (AP)--GlaxoSmithKline received a subpoena this month from the U.S. Attorney's Office in Colorado for an investigation of the marketing and promotion of several of the company's best-selling products, according to a regulatory filing.
 
GlaxoSmithKline spokeswoman Mary Anne Rhyne said the products cited in the investigation include respiratory drugs Flovent and Advair; Imitrex, used to treat migraines and cluster headaches; anti-epilepsy drug Lamictal; Paxil, used to treat depression, panic, (etc), anti-viral drug Valtrex; and anti-depressant Wellbutrin.
 
http://seattlepi.nwsource.com/business/apbiz_story.asp?category=1310& ;slug=Earns%20GlaxoSmithKline
 
GlaxoSmithKline reports drop in 4Q profit
 
By MICHAEL MCDONOUGH
ASSOCIATED PRESS WRITER
 
LONDON -- Pharmaceuticals giant GlaxoSmithKline PLC said Thursday that legal costs and a decline in sales of the anti-depressant Paxil helped squeeze fourth-quarter net income by 15.5 percent.
 
The London-based company said net income for the three months ending Dec. 31, 2003 was 790 million pounds (US$1.41 billion), down from 935 million pounds in the same quarter of 2002.
IP Logged

www.clusterbusters.com
Lizzie2
CH.com Alumnus
New Board Hall of Famer
USA 
*****




"L'Chaim"~Hebre w Toast~"To Life"

  Lizzie52004  
Email

Gender: female
Posts: 4458
Re: Bad day for Glaxo
« Reply #1 on: Feb 14th, 2004, 1:00pm »
Quote Quote Modify Modify

Sounds similar to what happened to Pfizer when they were caught pushing neurontin off-label for a variety of conditions that there is no proof of it helping.  People were put on rediculously high doses with no sign of improvement, and no wonder...it wasn't ever going to improve those conditions!  There were even claims made that doctors were paid to prescribe neurontin to their patients.  But when it comes down to it, neurontin is still prescribed for a variety of off-label uses...despite it's bad press.  
 
Well both Glaxo and SmithKline have had numerous corporate partners.  Wonder if they will think about reshuffling again in spite of their recent loss in profits.  At any rate, despite whatever problems their into, it doesn't mean that these drugs aren't useful for the various conditions they are being used for.  Hopefully it won't scare doc's off from prescribing them.  Doesn't seemed to have stopped neurontin much anyways!  Guess we'll see!
 
IP Logged





forgetfulnot
Guest

Email

Re: Bad day for Glaxo
« Reply #2 on: Feb 14th, 2004, 10:39pm »
Quote Quote Modify Modify Remove Remove

GlaxoSmithKline, by the way Liz that is all one company, is most likly the the strongest pharmacutical co's. there is. Imiterex is approved for use on cluster headaches. Microsoft has about 45bln in cash yet their stock has droped the last few weeks. Do you think they are both a bunch of crooks and we shuld bail? Well, If you answer yes then who would you buy? Enron? Tyco? Hard to say but when you look at the charts, Glaxo......
Is a strong money making company with a lot of good things on the horizon. A small deal like this is like a little heartburn after lunch for them. Smiley
 
Lee
IP Logged
Lizzie2
CH.com Alumnus
New Board Hall of Famer
USA 
*****




"L'Chaim"~Hebre w Toast~"To Life"

  Lizzie52004  
Email

Gender: female
Posts: 4458
Re: Bad day for Glaxo
« Reply #3 on: Feb 14th, 2004, 11:54pm »
Quote Quote Modify Modify

i know it is all one company NOW...but it used to be GlaxoWellcome and SmithKlineBeecham....they haven't always been partners.  and if you reread what i wrote, i wasn't saying they should stop prescribing them or  that CH was off-label for imitrex.  they MIGHT be in trouble for pushing the meds for other off-label uses.  and also what i said was that hopefully doc's won't stop prescribing the meds just because the company is in a little hot water at the moment.  i NEVER said we should stop taking them...bail on trex, etc.
 
Don't jump down my throat without understanding what i'm writing please. Smiley
Lizz
IP Logged





forgetfulnot
Guest

Email

Re: Bad day for Glaxo
« Reply #4 on: Feb 15th, 2004, 1:07am »
Quote Quote Modify Modify Remove Remove

Quote:
Don't jump down my throat without understanding what i'm writing please

 
Sorry Liz, I did not mean to do that at all, just stating facts, no finger pointing, hell I'am to old to jump down your throat Grin
 
Lee
IP Logged
Pages: 1  Reply Reply Notify of replies Notify of replies Send Topic Send Topic Print Print

« Previous topic | Next topic »


Clusterheadaches.com Message Board » Powered by YaBB 1 Gold - SP 1.3.1!
YaBB © 2000-2003. All Rights Reserved.


©1998-2010 Web Vision Enterprises All rights reserved. All information on this site is protected by international copyright laws. You may not re-distribute any information from this site without written permission from Web Vision Enterprises and the webmaster of this site. Violators will be prosecuted.
You may view our privacy policy and financial disclosure statement here

test rss